3 research outputs found

    Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Get PDF

    The European Court of Human Rights and Same-Sex Marriage. The Consensus Approach

    No full text
    corecore